- Award ID
- HT940220F0010
- Sub-agency / office
- Defense Health Agency
- Award amount
- $3,179,144
- Period of performance
- Apr 3, 2020 – Oct 2, 2025
- NAICS
- 541611 — Administrative Management and Consulting Services
- PSC
- PSC R707
- Place of performance
- MCLEAN, VA, 221024257, USA
- Competition
- FULL AND OPEN COMPETITION · 4 offers
- Pricing
- FIRM FIXED PRICE
- Financial breakdown
- Current value $3,179,144 · Obligated $3,179,144 · Potential value $3,179,144 · Latest action obligation $-114,427
- Parent award
- GS00F045DA
Most recent · Modification P00014 · Jul 10, 2025 · $-114,427 action obligation · THE HEALTH PLAN INNOVATIVE SUPPORT (HPIS) PROGRAM SUPPORTS THE DEVELOPMENT AND IMPLEMENTATION OF UPCOMING TRICARE MANAGED CARE SUPPORT CONTRACTS (T-5). · HT940220F0010
Modification P00013 · May 28, 2025 · $80,574 action obligation · THE HEALTH PLAN INNOVATIVE SUPPORT (HPIS) PROGRAM SUPPORTS THE DEVELOPMENT AND IMPLEMENTATION OF UPCOMING TRICARE MANAGED CARE SUPPORT CONTRACTS (T-5). · HT940220F0010
Modification P00012 · Feb 14, 2025 · $161,149 action obligation · THE HEALTH PLAN INNOVATIVE SUPPORT (HPIS) PROGRAM SUPPORTS THE DEVELOPMENT AND IMPLEMENTATION OF UPCOMING TRICARE MANAGED CARE SUPPORT CONTRACTS (T-5). · HT940220F0010
Modification P00011 · Jan 29, 2025 · $-23,221 action obligation · THE HEALTH PLAN INNOVATIVE SUPPORT (HPIS) PROGRAM SUPPORTS THE DEVELOPMENT AND IMPLEMENTATION OF UPCOMING TRICARE MANAGED CARE SUPPORT CONTRACTS (T-5). · HT940220F0010
Modification P00010 · Mar 19, 2024 · $939,460 action obligation · COST ESTIMATING AND PHARMACY BENEFIT OPTIMIZATION EFFORTS. · HT940220F0010
Modification P00009 · Mar 15, 2024 · $-89,108 action obligation · TPHARM5 COST ESTIMATING AND PHARMACY BENEFIT OPTIMIZATION EFFORTS. · HT940220F0010
Modification P00008 · Aug 11, 2023 · $408,989 action obligation · TRICARE PHARMACY 5TH GENERATION COST ESTIMATING AND PHARMACY BENEFIT OPTIMIZATION EFFORTS. · HT940220F0010
Modification P00007 · Jun 29, 2023 · $0 action obligation · THE TASK 2 VENDOR WILL SUPPORT TPHARM5 COST ESTIMATING AND PHARMACY BENEFIT OPTIMIZATION EFFORTS. · HT940220F0010
Modification P00006 · Mar 30, 2023 · $493,960 action obligation · THE TASK 2 VENDOR WILL SUPPORT TPHARM5 COST ESTIMATING AND PHARMACY BENEFIT OPTIMIZATION EFFORTS. · HT940220F0010
Modification P00005 · Aug 10, 2022 · $-61,820 action obligation · THE TASK 2 VENDOR WILL SUPPORT TPHARM5 COST ESTIMATING AND PHARMACY BENEFIT OPTIMIZATION EFFORTS. · HT940220F0010
Modification P00004 · Mar 23, 2022 · $484,662 action obligation · THE TASK 2 VENDOR WILL SUPPORT TPHARM5 COST ESTIMATING AND PHARMACY BENEFIT OPTIMIZATION EFFORTS. · HT940220F0010
Modification P00003 · Sep 22, 2021 · $-107,347 action obligation · THE TASK 2 VENDOR WILL SUPPORT TPHARM5 COST ESTIMATING AND PHARMACY BENEFIT OPTIMIZATION EFFORTS. · HT940220F0010
Modification P00002 · Mar 23, 2021 · $483,594 action obligation · THE TASK 2 VENDOR WILL SUPPORT TPHARM5 COST ESTIMATING AND PHARMACY BENEFIT OPTIMIZATION EFFORTS. · HT940220F0010
Modification P00001 · May 1, 2020 · $0 action obligation · THE TASK 2 VENDOR WILL SUPPORT TPHARM5 COST ESTIMATING AND PHARMACY BENEFIT OPTIMIZATION EFFORTS. · HT940220F0010
Modification 0 · Apr 3, 2020 · $522,678 action obligation · THE TASK 2 VENDOR WILL SUPPORT TPHARM5 COST ESTIMATING AND PHARMACY BENEFIT OPTIMIZATION EFFORTS. · HT940220F0010